Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Niccoli

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Journal of Personalized Medicine|September 28, 2023
ReLiFiRa (Real Life Filgotinib in Rheumatoid Arthritis): Retrospective Study of Efficacy and Safety in Common Clinical PracticeMaurizio Benucci, Marco Bardelli, Massimiliano Cazzato, et al.
Journal of Personalized Medicine|July 27, 2024
Efficacy and Safety of Filgotinib in Rheumatoid Arthritis Patients Aged over and under 65 Years (ENANTIA-65)Maurizio Benucci, Marco Bardelli, Massimiliano Cazzato, et al.
Journal of Personalized Medicine|November 26, 2024
Secukinumab for the Treatment of Axial Spondyloarthritis: Long-Term Real-Life Data from Five Italian Referral CentersStefano Gentileschi, Carlo Cannistrà, Carla Gaggiano, et al.
Clinical and Experimental Medicine|February 5, 2025
Real-world effectiveness and retention rate of upadacitinib in patients with rheumatoid arthritis: results from a multicentre studyCaterina Baldi, Stefano Gentileschi, Francesca Li Gobbi, et al.
Seminars in Arthritis and Rheumatism|November 27, 2015
Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritisFabrizio Cantini, Laura Niccoli, Carlotta Nannini, et al.
Frontiers in Pharmacology|January 11, 2020
Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective StudySalvatore D'Angelo, Fabrizio Cantini, Roberta Ramonda, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 3, 2022
Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal studyChiara Farroni, Alessandra Aiello, Andrea Picchianti-Diamanti, et al.
Science Advances|November 14, 2020
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortalityJustin Stebbing, Ginés Sánchez Nievas, Marco Falcone, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Journal of Personalized Medicine|September 28, 2023
ReLiFiRa (Real Life Filgotinib in Rheumatoid Arthritis): Retrospective Study of Efficacy and Safety in Common Clinical PracticeMaurizio Benucci, Marco Bardelli, Massimiliano Cazzato, et al.
Journal of Personalized Medicine|July 27, 2024
Efficacy and Safety of Filgotinib in Rheumatoid Arthritis Patients Aged over and under 65 Years (ENANTIA-65)Maurizio Benucci, Marco Bardelli, Massimiliano Cazzato, et al.
Journal of Personalized Medicine|November 26, 2024
Secukinumab for the Treatment of Axial Spondyloarthritis: Long-Term Real-Life Data from Five Italian Referral CentersStefano Gentileschi, Carlo Cannistrà, Carla Gaggiano, et al.
Clinical and Experimental Medicine|February 5, 2025
Real-world effectiveness and retention rate of upadacitinib in patients with rheumatoid arthritis: results from a multicentre studyCaterina Baldi, Stefano Gentileschi, Francesca Li Gobbi, et al.
Seminars in Arthritis and Rheumatism|November 27, 2015
Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritisFabrizio Cantini, Laura Niccoli, Carlotta Nannini, et al.
Frontiers in Pharmacology|January 11, 2020
Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective StudySalvatore D'Angelo, Fabrizio Cantini, Roberta Ramonda, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 3, 2022
Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal studyChiara Farroni, Alessandra Aiello, Andrea Picchianti-Diamanti, et al.
Science Advances|November 14, 2020
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortalityJustin Stebbing, Ginés Sánchez Nievas, Marco Falcone, et al.
Pageof 5